Saravana Kumar Jaganathan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saravana Kumar Jaganathan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Abiola Bakare
School of Engineering and Physical Sciences, University of Lincoln, Lincoln, LN6 7TS, United Kingdom
1 shared publication- Chhavi Sharma
University Centre for Research and Development, University Institute of Biotechnology, Chandigarh University, Mohali, India
1 shared publication Ghousiya Begum K
School of Electrical and Electronics Engineering, SASTRA Deemed to be University, Thanjavur, 613 401, Tamil Nadu, India
1 shared publicationHemanth Ponnambalath Mohandas
Abbott Diabetes Care, Device Development, Alameda, CA 94502
1 shared publicationK Adalarasu
School of Electrical and Electronics Engineering, SASTRA Deemed to be University, Thanjavur, 613 401, Tamil Nadu, India
1 shared publication- Madhusudhan Alle
Department of Chemistry, The University of Memphis, Memphis, TN 38152, USA
1 shared publication
Latest Publications
- Open Access
- 28 July 2026
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 38, 9922025
Predicting blood–polymer interactions in electrospun nanofiber systems using interpretable AI models: A meta-analytical approach
Advanced biomaterials are essential for restoring tissue function, yet ensuring the safety of blood-contacting devices remains a significant challenge. This study presents a data-driven framework to predict the hemocompatibility of electrospun nanocomposites by correlating their nanoscale physicochemical signatures with biological outcomes. Using a curated dataset of 99 experimental samples, we evaluated the predictive power of support vector machines (SVM), linear discriminant analysis (LDA), and multilayer perceptron (MLP) architectures. To address data scarcity and class imbalance, the synthetic minority oversampling technique (SMOTE) was integrated into a 10-fold cross-validation pipeline. Results indicate that the MLP model provides superior predictive performance, achieving a validation accuracy of 98.4%. Furthermore, the application of explainable AI (XAI) methods to elucidate feature contributions revealed that surface roughness, contact angle, and thermal degradation onset are primary determinants of blood compatibility, potentially eliminating the need for redundant coagulation assays. This research establishes a cost-effective, non-invasive methodology for the high-throughput screening of next-generation medical device coatings.
- 28 July 2026
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 38, 9922025
Open AccessPredicting blood–polymer interactions in electrospun nanofiber systems using interpretable AI models: A meta-analytical approach
Advanced biomaterials are essential for restoring tissue function, yet ensuring the safety of blood-contacting devices remains a significant challenge. This study presents a data-driven framework to predict the hemocompatibility of electrospun nanocomposites by correlating their nanoscale physicochemical signatures with biological outcomes. Using a curated dataset of 99 experimental samples, we evaluated the predictive power of support vector machines (SVM), linear discriminant analysis (LDA), and multilayer perceptron (MLP) architectures. To address data scarcity and class imbalance, the synthetic minority oversampling technique (SMOTE) was integrated into a 10-fold cross-validation pipeline. Results indicate that the MLP model provides superior predictive performance, achieving a validation accuracy of 98.4%. Furthermore, the application of explainable AI (XAI) methods to elucidate feature contributions revealed that surface roughness, contact angle, and thermal degradation onset are primary determinants of blood compatibility, potentially eliminating the need for redundant coagulation assays. This research establishes a cost-effective, non-invasive methodology for the high-throughput screening of next-generation medical device coatings.
- Open Access
Carbon Based Polymeric Nanocomposite Hydrogel Bioink: A Review
Carbon-based polymeric nanocomposite hydrogels (NCHs) represent a groundbreaking advancement in biomedical materials by integrating nanoparticles such as graphene, carbon nanotubes (CNTs), carbon dots (CDs), and activated charcoal (AC) into polymeric matrices. These nanocomposites significantly enhance the mechanical strength, electrical conductivity, and bioactivity of hydrogels, making them highly effective for drug delivery, tissue engineering (TE), bioinks for 3D Bioprinting, and wound healing applications. Graphene improves the mechanical and electrical properties of hydrogels, facilitating advanced tissue scaffolding and drug delivery systems. CNTs, with their exceptional mechanical strength and conductivity, enhance rheological properties, facilitating their use as bioinks in supporting complex 3D bioprinting tasks for neural, bone, and cardiac tissues by mimicking the natural structure of tissues. CDs offer fluorescence capabilities for theranostic applications, integrating imaging and therapeutic functions. AC enhances mechanical strength, biocompatibility, and antibacterial effectiveness, making it suitable for wound healing and electroactive scaffolds. Despite these promising features, challenges remain, such as optimizing nanoparticle concentrations, ensuring biocompatibility, achieving uniform dispersion, scaling up production, and integrating multiple functionalities. Addressing these challenges through continued research and development is crucial for advancing the clinical and industrial applications of these innovative hydrogels.
Open AccessCarbon Based Polymeric Nanocomposite Hydrogel Bioink: A Review
Carbon-based polymeric nanocomposite hydrogels (NCHs) represent a groundbreaking advancement in biomedical materials by integrating nanoparticles such as graphene, carbon nanotubes (CNTs), carbon dots (CDs), and activated charcoal (AC) into polymeric matrices. These nanocomposites significantly enhance the mechanical strength, electrical conductivity, and bioactivity of hydrogels, making them highly effective for drug delivery, tissue engineering (TE), bioinks for 3D Bioprinting, and wound healing applications. Graphene improves the mechanical and electrical properties of hydrogels, facilitating advanced tissue scaffolding and drug delivery systems. CNTs, with their exceptional mechanical strength and conductivity, enhance rheological properties, facilitating their use as bioinks in supporting complex 3D bioprinting tasks for neural, bone, and cardiac tissues by mimicking the natural structure of tissues. CDs offer fluorescence capabilities for theranostic applications, integrating imaging and therapeutic functions. AC enhances mechanical strength, biocompatibility, and antibacterial effectiveness, making it suitable for wound healing and electroactive scaffolds. Despite these promising features, challenges remain, such as optimizing nanoparticle concentrations, ensuring biocompatibility, achieving uniform dispersion, scaling up production, and integrating multiple functionalities. Addressing these challenges through continued research and development is crucial for advancing the clinical and industrial applications of these innovative hydrogels.